- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIOA B | SEK 195.60 | -0.2% | -16.7% | SEK 17.3b | SEK 322.00 | PS103.4x | E51.3% | 0% | ||
BONEX | SEK 374.80 | 0% | 85.7% | SEK 24.7b | SEK 422.33 | PE272.3x | E73.1% | n/a | ||
VITR | SEK 208.80 | 4.1% | 24.2% | SEK 28.3b | SEK 272.00 | PS8x | E96.8% | 0.5% |
Page 1 of 1